Equities analysts expect that Beam Therapeutics Inc. (NASDAQ:BEAM) will announce sales of $8.75 million for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Beam Therapeutics’ earnings. The lowest sales estimate is $7.50 million and the highest is $10.00 million. Beam Therapeutics posted sales of $10,000.00 during the same quarter last […]
